Traws Pharma, Inc.
TRAW · Pharmaceutical Preparations
Latest available SEC filing: SCHEDULE 13G ·
Latest disclosures
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form SCHEDULE 13G/A
SEC filing · Filed
-
Form SCHEDULE 13G/A
SEC filing · Filed
-
Form SCHEDULE 13G
SEC filing · Filed
-
Form SCHEDULE 13G/A
SEC filing · Filed
-
Pauza Charles David: Form 4
Insider disclosure · Filed · Report period 09 Jul 2026
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001130598 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- TRAW on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 12 Penns Trail, Newtown, PA, 18940
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- Onconova Therapeutics, Inc. (to 01 Apr 2024), ONCONOVA THERAPEUTICS INC (to 26 May 2009)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields